As a qualified healthcare professional, you can access medicines through Early Access Programs*
(*also known as expanded access, named patient, compassionate use or managed access).
Inceptua is running in partnership with pharmaceutical clients.
Inceptua supports a large number of pharmaceutical & biotech companies through its management of Early Access Programs for their assets.
Currently Inceptua is managing programs covering a wide range of rare diseases, oncolog and infectious diseases, allowing physicians to access these medicines prior to their commercial approval.
The full list of ongoing pre-approval access programs being managed by Inceptua, along with their inclusion criteria, and geographic scope, can be viewed by registering with our IMAP portal
Supporting you through the entire process
- Ethical and compliant
- Directly partnered with the manufacturer
- Dedicated country expert Medicines Access Advisors
- Available by mail or phone
- Local language support
- Unparalleled regulatory guidance
- Easy-to-use online platform
- Global network of warehouses
- Rapid Response and delivery